Ghost Tree Capital, LLC Merus N.V. Transaction History

Ghost Tree Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$13.98 - $29.25 $2.1 Million - $4.39 Million	-150,000 Reduced 37.5%	250,000 $5.66 Million
Q1 2022 May 16, 2022	BUY	$23.58 - $30.91 $1.18 Million - $1.55 Million	50,000 Added 14.29%	400,000 $10.6 Million
Q4 2021 Feb 16, 2022	BUY	$20.0 - $32.29 $5.5 Million - $8.88 Million	275,000 Added 366.67%	350,000 $11.1 Million
Q2 2021 Aug 11, 2021	BUY	$20.0 - $25.48 $1.5 Million - $1.91 Million	75,000 New	75,000 $1.58 Million

200

61.9M

243K

300K

Ticker MRUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,878,200
Market Cap $2.28B
Description
Merus N.V., a clinical-stage immuno-oncology company, engages in the discovery and development of bispecific antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer, as well as in Phase...

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ghost Tree Capital, LLC with notifications on news.